A second study explored the effect of FLT3 inhibitors on glycolytic activity of FLT3ITD-mutated AML cells, showing that these inhibitors exert a more pronounced inhibitory effect on the glycolytic activity, but a less marked inhibition of TCA cycle activity and respiratory function [202]. Here, FLT3 is linked to acute myeloid leukemia.